Nombre del producto:3-(4-Benzyl-3-oxo-7-(trifluoromethyl)-3,4-dihydroquinoxalin-2-yl)propanoic acid

IUPAC Name:3-[4-benzyl-3-oxo-7-(trifluoromethyl)-3,4-dihydroquinoxalin-2-yl]propanoic acid

CAS:565191-92-6
Fórmula molecular:C19H15F3N2O3
Pureza:97%
Número de catálogo:CM221882
Peso molecular:376.34

Unidad de embalaje Stock disponible Precio($) Cantidad
CM221882-1g in stock ƿŗǪ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :565191-92-6
Fórmula molecular:C19H15F3N2O3
Punto de fusión:-
Código de sonrisas:O=C(O)CCC1=NC2=C(C=CC(C(F)(F)F)=C2)N(CC3=CC=CC=C3)C1=O
Densidad:
Número de catálogo:CM221882
Peso molecular:376.34
Punto de ebullición:
Nº Mdl:MFCD03964648
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos